| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Chemical Pathology [Y. M. D. L., L. Y. S. C., J. Z., N. M. H.], Anatomical and Cellular Pathology [K-W. L., J. C. K. L., D. P. H.], and Clinical Oncology and the Sir YK Pao Cancer Center [S-F. L. A. T. C. C., P. J. J.], The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region
Using real-time quantitative PCR, cell-free EBV DNA was detectable in the plasma of 96% (55 of 57) of nasopharyngeal carcinoma (NPC) patients (median concentration, 21058 copies/ml) and 7% (3 of 43) of controls (median concentration, 0 copies/ml). Advanced-stage NPC patients had higher plasma EBV DNA levels than those with early-stage disease. At 1 month after completion of radiotherapy, plasma EBV DNA was undetecTable in 7 of 15 subjects (47%) but remained high in the remaining 8 subjects (53%). Clinical examination revealed that all of the former seven subjects had complete tumor regression, whereas six of the eight latter subjects exhibited evidence of disease persistence or had developed distant metastases. These results suggest that quantitative analysis of plasma EBV DNA may be a useful clinical and research tool in the screening and monitoring of NPC patients.
This article has been cited by other articles:
![]() |
K. W. Ong, M. Teo, V. Lee, D. Ong, A. Lee, C. S. Tan, A. Vathsala, and H. C. Toh Expression of EBV Latent Antigens, Mammalian Target of Rapamycin, and Tumor Suppression Genes in EBV-Positive Smooth Muscle Tumors: Clinical and Therapeutic Implications Clin. Cancer Res., September 1, 2009; 15(17): 5350 - 5358. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. C. Chan, E. Felip, and On behalf of the ESMO Guidelines Working Group Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann. Onc., May 1, 2009; 20(suppl_4): iv123 - iv125. [Full Text] [PDF] |
||||
![]() |
Y.M. D. Lo and R. W.K. Chiu Next-Generation Sequencing of Plasma/Serum DNA: An Emerging Research and Molecular Diagnostic Tool Clin. Chem., April 1, 2009; 55(4): 607 - 608. [Full Text] [PDF] |
||||
![]() |
M. FREMONT, K. METZGER, H. RADY, J. HULSTAERT, and K. DE MEIRLEIR Detection of Herpesviruses and Parvovirus B19 in Gastric and Intestinal Mucosa of Chronic Fatigue Syndrome Patients In Vivo, March 1, 2009; 23(2): 209 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Hsieh, R. Soo, B.-K. Peh, T. Loh, D. Dong, D. Soh, L.-S. Wong, S. Green, J. Chiao, C.-Y. Cui, et al. Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer Clin. Cancer Res., February 15, 2009; 15(4): 1435 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-P. Chang, S.-P. Hao, J.-H. Chang, C.-C. Wu, N.-M. Tsang, Y.-S. Lee, C.-L. Hsu, S.-H. Ueng, S.-C. Liu, Y.-L. Liu, et al. Macrophage Inflammatory Protein-3{alpha} Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes Clin. Cancer Res., November 1, 2008; 14(21): 6979 - 6987. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. A. Chan, P. B. S. Lai, T. S. K. Mok, H. L. Y. Chan, C. Ding, S. W. Yeung, and Y. M. D. Lo Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma Clin. Chem., September 1, 2008; 54(9): 1528 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Garcia, V. Garcia, C. Pena, G. Dominguez, J. Silva, R. Diaz, P. Espinosa, M. J. Citores, M. Collado, and F. Bonilla Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched RNA, July 1, 2008; 14(7): 1424 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gulley and W. Tang Laboratory Assays for Epstein-Barr Virus-Related Disease J. Mol. Diagn., July 1, 2008; 10(4): 279 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.C. A. Chan, S.-F. Leung, S.-W. Yeung, A. T.C. Chan, and Y.M. D. Lo Persistent Aberrations in Circulating DNA Integrity after Radiotherapy Are Associated with Poor Prognosis in Nasopharyngeal Carcinoma Patients Clin. Cancer Res., July 1, 2008; 14(13): 4141 - 4145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Chia, A. Leung, T. Krushel, N. M. Alajez, K. W. Lo, P. Busson, H. J. Klamut, C. Bastianutto, and F.-F. Liu Nuclear Factor-Y and Epstein Barr Virus in Nasopharyngeal Cancer Clin. Cancer Res., February 15, 2008; 14(4): 984 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Garcia, C. Pena, V. Garcia, G. Dominguez, C. Munoz, J. Silva, I. Millan, R. Diaz, Y. Lorenzo, R. Rodriguez, et al. Prognostic Value of LISCH7 mRNA in Plasma and Tumor of Colon Cancer Patients Clin. Cancer Res., November 1, 2007; 13(21): 6351 - 6358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Wong, B. C. K. Wong, K. C. A. Chan, G. M. Joynt, F. Y. H. Y. Yap, C. W. K. Lam, N. Lee, S. S. Lee, C. S. Cockram, J. J. Y. Sung, et al. Cytokine Profile in Fatal Human Immunodeficiency Virus Tuberculosis Epstein-Barr Virus Associated Hemophagocytic Syndrome Arch Intern Med, September 24, 2007; 167(17): 1901 - 1903. [Full Text] [PDF] |
||||
![]() |
O. Riesterer, L. Milas, and K. K. Ang Use of Molecular Biomarkers for Predicting the Response to Radiotherapy With or Without Chemotherapy J. Clin. Oncol., September 10, 2007; 25(26): 4075 - 4083. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hakim, C. Gibson, J. Pan, K. Srivastava, Z. Gu, M. J. Bankowski, and R. T. Hayden Comparison of Various Blood Compartments and Reporting Units for the Detection and Quantification of Epstein-Barr Virus in Peripheral Blood J. Clin. Microbiol., July 1, 2007; 45(7): 2151 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J-Y Lu, D-Y Chen, C-W Hsieh, J-L Lan, F-J Lin, and S-H Lin Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan Lupus, March 1, 2007; 16(3): 168 - 175. [Abstract] [PDF] |
||||
![]() |
H.-H. Chua, H.-H. Lee, S.-S. Chang, C.-C. Lu, T.-H. Yeh, T.-Y. Hsu, T.-H. Cheng, J.-T. Cheng, M.-R. Chen, and C.-H. Tsai Role of the TSG101 Gene in Epstein-Barr Virus Late Gene Transcription J. Virol., March 1, 2007; 81(5): 2459 - 2471. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C.S. Cho, T. T.C. Yip, R. K.C. Ngan, T.-T. Yip, V. N. Podust, C. Yip, H. H.Y. Yiu, V. Yip, W.-W. Cheng, V. W.S. Ma, et al. ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma Clin. Chem., February 1, 2007; 53(2): 241 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-f. Leung, B. Zee, B. B. Ma, E. P. Hui, F. Mo, M. Lai, K.C. A. Chan, L. Y.S. Chan, W.-h. Kwan, Y.M. D. Lo, et al. Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma J. Clin. Oncol., December 1, 2006; 24(34): 5414 - 5418. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Chang and H.-O. Adami The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1765 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C.K. Wong, K.C. A. Chan, A. T.C. Chan, S.-F. Leung, L. Y.S. Chan, K. C.K. Chow, and Y.M. D. Lo Reduced Plasma RNA Integrity in Nasopharyngeal Carcinoma Patients Clin. Cancer Res., April 15, 2006; 12(8): 2512 - 2516. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Garcia, J. M. Garcia, C. Pena, J. Silva, G. Dominguez, A. Hurtado, I. Alonso, R. Rodriguez, M. Provencio, and F. Bonilla Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential. Clin. Cancer Res., April 1, 2006; 12(7): 2095 - 2100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, L. Harris, H. Mamon, M. H. Kulke, W.-H. Liu, P. Zhu, and G. Mike Makrigiorgos Whole Genome Amplification of Plasma-Circulating DNA Enables Expanded Screening for Allelic Imbalance in Plasma J. Mol. Diagn., February 1, 2006; 8(1): 22 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gandhi, E. Lambley, J. Burrows, U. Dua, S. Elliott, P. J. Shaw, H. M. Prince, M. Wolf, K. Clarke, C. Underhill, et al. Plasma Epstein-Barr Virus (EBV) DNA Is a Biomarker for EBV-Positive Hodgkin's Lymphoma Clin. Cancer Res., January 15, 2006; 12(2): 460 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Espy, J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing Clin. Microbiol. Rev., January 1, 2006; 19(1): 165 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.C. A. Chan, A. T.C. Chan, S.-F. Leung, J. C.S. Pang, A. Y.M. Wang, J. H.M. Tong, K.-F. To, L. Y.S. Chan, L. L.S. Tam, N. Y.F. Chung, et al. Investigation into the Origin and Tumoral Mass Correlation of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Clin. Chem., November 1, 2005; 51(11): 2192 - 2195. [Full Text] [PDF] |
||||
![]() |
Q.-T. Le, C. D. Jones, T.-K. Yau, H. A. Shirazi, P. H. Wong, E. N. Thomas, B. K. Patterson, A. W.M. Lee, and J. L. Zehnder A Comparison Study of Different PCR Assays in Measuring Circulating Plasma Epstein-Barr Virus DNA Levels in Patients with Nasopharyngeal Carcinoma Clin. Cancer Res., August 15, 2005; 11(16): 5700 - 5707. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, K. Yang, A. Khafagi, Y. Tang, T. E. Carey, A. W. Opipari, R. Lieberman, P. A. Oeth, W. Lancaster, H. P. Klinger, et al. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies PNAS, May 24, 2005; 102(21): 7683 - 7688. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Gingeras, R. Higuchi, L. J. Kricka, Y.M. D. Lo, and C. T. Wittwer Fifty Years of Molecular (DNA/RNA) Diagnostics Clin. Chem., March 1, 2005; 51(3): 661 - 671. [Full Text] [PDF] |
||||
![]() |
L. C.W. Lit, K.C. A. Chan, S.-F. Leung, K. I.K. Lei, L. Y.S. Chan, K. C.K. Chow, A. T.C. Chan, and Y.M. D. Lo Distribution of Cell-Free and Cell-Associated Epstein-Barr Virus (EBV) DNA in the Blood of Patients with Nasopharyngeal Carcinoma and EBV-Associated Lymphoma Clin. Chem., October 1, 2004; 50(10): 1842 - 1845. [Full Text] [PDF] |
||||
![]() |
S. Holdenrieder, P. Stieber, J. von Pawel, H. Raith, D. Nagel, K. Feldmann, and D. Seidel Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer Clin. Cancer Res., September 15, 2004; 10(18): 5981 - 5987. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T.C. Chan, B. B.Y. Ma, Y.M. D. Lo, S.F. Leung, W.H. Kwan, E. P. Hui, T. S.K. Mok, M. Kam, L. S. Chan, S. K.W. Chiu, et al. Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA J. Clin. Oncol., August 1, 2004; 22(15): 3053 - 3060. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sriuranpong, A. Mutirangura, J. W. Gillespie, V. Patel, P. Amornphimoltham, A. A. Molinolo, V. Kerekhanjanarong, S. Supanakorn, P. Supiyaphun, S. Rangdaeng, et al. Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays Clin. Cancer Res., August 1, 2004; 10(15): 4944 - 4958. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ding, R. W. K. Chiu, T. K. Lau, T. N. Leung, L. C. Chan, A. Y. Y. Chan, P. Charoenkwan, I. S. L. Ng, H.-y. Law, E. S. K. Ma, et al. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis PNAS, July 20, 2004; 101(29): 10762 - 10767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Lin, W.-Y. Wang, K. Y. Chen, Y.-H. Wei, W.-M. Liang, J.-S. Jan, and R.-S. Jiang Quantification of Plasma Epstein-Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma N. Engl. J. Med., June 10, 2004; 350(24): 2461 - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Krishna, S. James, J. Kattoor, and P. Balaram Serum EBV DNA as a Biomarker in Primary Nasopharyngeal Carcinoma of Indian Origin Jpn. J. Clin. Oncol., June 1, 2004; 34(6): 307 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chang, S.-S. Chang, H.-H. Lee, S.-L. Doong, K. Takada, and C.-H. Tsai Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference J. Gen. Virol., June 1, 2004; 85(6): 1371 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Glaser, J. L. Hsu, and M. L. Gulley Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Wong, D. L.-W. Kwong, J. S.-T. Sham, W. I. Wei, Y.-L. Kwong, and A. P.-W. Yuen Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma Clin. Cancer Res., April 1, 2004; 10(7): 2401 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Yu, Y. M. D. Lo, G. M. Tse, K. C. A. Chan, A. B. W. Chan, K. C. K. Chow, T. K. F. Ma, A. C. Vlantis, S. F. Leung, C. A. van Hasselt, et al. Quantitative Analysis of Cell-Free Epstein-Barr Virus DNA in Plasma of Patients with Nonnasopharyngeal Head and Neck Carcinomas Clin. Cancer Res., March 1, 2004; 10(5): 1726 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. von Knobloch, H. Brandt, A. J. Schrader, A. Heidenreich, and R. Hofmann Molecular Serological Detection of DNA Alterations in Transitional Cell Carcinoma Is Highly Sensitive and Stage Independent Clin. Cancer Res., February 1, 2004; 10(3): 988 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-f. Leung, J. S. Tam, A. T.C. Chan, B. Zee, L. Y.S. Chan, D. P. Huang, A. Van Hasselt, P. J. Johnson, and Y.M. D. Lo Improved Accuracy of Detection of Nasopharyngeal Carcinoma by Combined Application of Circulating Epstein-Barr Virus DNA and Anti-Epstein-Barr Viral Capsid Antigen IgA Antibody Clin. Chem., February 1, 2004; 50(2): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Polstra, R. van den Burg, J. Goudsmit, and M. Cornelissen Human Herpesvirus 8 Load in Matched Serum and Plasma Samples of Patients with AIDS-Associated Kaposi's Sarcoma J. Clin. Microbiol., December 1, 2003; 41(12): 5488 - 5491. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Asada, S. Miyagawa, Y. Sumikawa, Y. Yamaguchi, S. Itami, S. Suguri, M. Harada, Y. Tokura, S. Ishihara, S. Ohshima, et al. CD4+ T-Lymphocyte-Induced Epstein-Barr Virus Reactivation in a Patient With Severe Hypersensitivity to Mosquito Bites and Epstein-Barr Virus-Infected NK Cell Lymphocytosis Arch Dermatol, December 1, 2003; 139(12): 1601 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wadowsky, S. Laus, M. Green, S. A. Webber, and D. Rowe Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR J. Clin. Microbiol., November 1, 2003; 41(11): 5245 - 5249. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. H. To, K. C. A. Chan, S.-F. Leung, L. Y. S. Chan, K.-F. To, A. T. C. Chan, P. J. Johnson, and Y. M. D. Lo Rapid Clearance of Plasma Epstein-Barr Virus DNA After Surgical Treatment of Nasopharyngeal Carcinoma Clin. Cancer Res., August 1, 2003; 9(9): 3254 - 3259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-f. Leung, Y. M. D. Lo, A. T. C. Chan, K.-f. To, E. To, L. Y. S. Chan, B. Zee, D. P. Huang, and P. J. Johnson Disparity of Sensitivities in Detection of Radiation-Naive and Postirradiation Recurrent Nasopharyngeal Carcinoma of the Undifferentiated Type by Quantitative Analysis of Circulating Epstein-Barr Virus DNA1 ,2 Clin. Cancer Res., August 1, 2003; 9(9): 3431 - 3434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.C. A. Chan, J. Zhang, A. T.C. Chan, K. I.K. Lei, S.-F. Leung, L. Y.S. Chan, K. C.K. Chow, and Y.M. D. Lo Molecular Characterization of Circulating EBV DNA in the Plasma of Nasopharyngeal Carcinoma and Lymphoma Patients Cancer Res., May 1, 2003; 63(9): 2028 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H.M. Chan, K. M. Chow, A. T.C. Chan, C. B. Leung, L. Y.S. Chan, K. C.K. Chow, C. W. Lam, and Y.M. D. Lo Quantitative Analysis of Pleural Fluid Cell-free DNA as a Tool for the Classification of Pleural Effusions Clin. Chem., May 1, 2003; 49(5): 740 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, H.-H. Chua, S.-Y. Chen, J.-Y. Chen, and C.-H. Tsai Regulation of Matrix Metalloproteinase-1 by Epstein-Barr Virus Proteins Cancer Res., January 1, 2003; 63(1): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gius and C. N. Coleman Treatment of Nasopharyngeal Cancer: Raising the "Barr" J Natl Cancer Inst, November 6, 2002; 94(21): 1594 - 1595. [Full Text] [PDF] |
||||
![]() |
A. T. C. Chan, Y. M. D. Lo, B. Zee, L. Y. S. Chan, B. B. Y. Ma, S.-F. Leung, F. Mo, M. Lai, S. Ho, D. P. Huang, et al. Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal Carcinoma J Natl Cancer Inst, November 6, 2002; 94(21): 1614 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Dworkin, T. M. Gibler, and R. N. Van Gelder Real-Time Quantitative Polymerase Chain Reaction Diagnosis of Infectious Posterior Uveitis Arch Ophthalmol, November 1, 2002; 120(11): 1534 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Johnson and Y.M. D. Lo Plasma Nucleic Acids in the Diagnosis and Management of Malignant Disease Clin. Chem., August 1, 2002; 48(8): 1186 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Wang, Y.-C. Chien, J.-S. Jan, C.-M. Chueh, and J.-C. Lin Consistent Sequence Variation of Epstein-Barr Virus Nuclear Antigen 1 in Primary Tumor and Peripheral Blood Cells of Patients with Nasopharyngeal Carcinoma Clin. Cancer Res., August 1, 2002; 8(8): 2586 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. M. Tong, R. K. Y. Tsang, K.-W. Lo, J. K. S. Woo, J. Kwong, M. W. Y. Chan, A. R. Chang, C. A. van Hasselt, D. P. Huang, and K.-F. To Quantitative Epstein-Barr Virus DNA Analysis and Detection of Gene Promoter Hypermethylation in Nasopharyngeal (NP) Brushing Samples from Patients with NP Carcinoma Clin. Cancer Res., August 1, 2002; 8(8): 2612 - 2619. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. C. Chan, P. M. L. Teo, and P. J. Johnson Nasopharyngeal carcinoma Ann. Onc., July 1, 2002; 13(7): 1007 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Silva, R Rodriguez, J M Garcia, C Munoz, J Silva, G Dominguez, M Provencio, P Espana, and F Bonilla Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells Gut, April 1, 2002; 50(4): 530 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dominguez, J. Carballido, J. Silva, J. M. Silva, J. M. Garcia, J. Menendez, M. Provencio, P. Espana, and F. Bonilla p14ARF Promoter Hypermethylation in Plasma DNA as an Indicator of Disease Recurrence in Bladder Cancer Patients Clin. Cancer Res., April 1, 2002; 8(4): 980 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. C. Ngan, T. T. C. Yip, W.-W. Cheng, J. K. C. Chan, W. C. S. Cho, V. W. S. Ma, K.-K. Wan, S.-K. Au, C.-K. Law, and W.-H. Lau Circulating Epstein-Barr Virus DNA in Serum of Patients with Lymphoepithelioma-like Carcinoma of the Lung: A Potential Surrogate Marker for Monitoring Disease Clin. Cancer Res., April 1, 2002; 8(4): 986 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Mackay, K. E. Arden, and A. Nitsche Real-time PCR in virology Nucleic Acids Res., March 15, 2002; 30(6): 1292 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Dong, S. I. Pai, S.-H. Rha, A. Hildesheim, R. J. Kurman, P. E. Schwartz, R. Mortel, L. McGowan, M. D. Greenberg, W. A. Barnes, et al. Detection and Quantitation of Human Papillomavirus DNA in the Plasma of Patients with Cervical Carcinoma Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 3 - 6. [Abstract] [Full Text] |
||||
![]() |
K. I. K. Lei, L. Y. S. Chan, W.-Y. Chan, P. J. Johnson, and Y. M. D. Lo Diagnostic and Prognostic Implications of Circulating Cell-free Epstein-Barr Virus DNA in Natural Killer/T-Cell Lymphoma Clin. Cancer Res., January 1, 2002; 8(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and Neck Cancer N. Engl. J. Med., December 27, 2001; 345(26): 1890 - 1900. [Full Text] [PDF] |
||||
![]() |
J. M. Silva, G. Dominguez, J. Silva, J. M. Garcia, A. Sanchez, O. Rodriguez, M. Provencio, P. Espana, and F. Bonilla Detection of Epithelial Messenger RNA in the Plasma of Breast Cancer Patients Is Associated with Poor Prognosis Tumor Characteristics Clin. Cancer Res., September 1, 2001; 7(9): 2821 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. I. Wei Nasopharyngeal Cancer: Current Status of Management: A New York Head and Neck Society Lecture Arch Otolaryngol Head Neck Surg, July 1, 2001; 127(7): 766 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. D. Lo, W. Y. Chan, E. K. W. Ng, L. Y. S. Chan, P. B. S. Lai, J. S. Tam, and S. C. S. Chung Circulating Epstein-Barr Virus DNA in the Serum of Patients with Gastric Carcinoma Clin. Cancer Res., July 1, 2001; 7(7): 1856 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Lin, K. Y. Chen, W.-Y. Wang, J.-S. Jan, W.-M. Liang, C.-S. Tsai, and Y.-H. Wei Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and Survival J. Clin. Oncol., May 15, 2001; 19(10): 2607 - 2615. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. C. Stevens, I. Pronk, and J. M. Middeldorp Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical Specimen J. Clin. Microbiol., April 1, 2001; 39(4): 1211 - 1216. [Abstract] [Full Text] |
||||
![]() |
W. J. Jabs, H. Hennig, M. Kittel, K. Pethig, F. Smets, P. Bucsky, H. Kirchner, and H. J. Wagner Normalized Quantification by Real-Time PCR of Epstein-Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative Disorders J. Clin. Microbiol., February 1, 2001; 39(2): 564 - 569. [Abstract] [Full Text] |
||||
![]() |
M. L. Gulley Molecular Diagnosis of Epstein-Barr Virus-Related Diseases J. Mol. Diagn., February 1, 2001; 3(1): 1 - 10. [Abstract] [Full Text] |
||||
![]() |
J. Yang, Q. Tao, I. W. Flinn, P. G. Murray, L. E. Post, H. Ma, S. Piantadosi, M. A. Caligiuri, and R. F. Ambinder Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response Blood, December 15, 2000; 96(13): 4055 - 4063. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. D. Lo, A. T. C. Chan, L. Y. S. Chan, S.-F. Leung, C.-W. Lam, D. P. Huang, and P. J. Johnson Molecular Prognostication of Nasopharyngeal Carcinoma by Quantitative Analysis of Circulating Epstein-Barr Virus DNA Cancer Res., December 1, 2000; 60(24): 6878 - 6881. [Abstract] [Full Text] |
||||
![]() |
R. B. Capone, S. I. Pai, W. M. Koch, M. L. Gillison, H. N. Danish, W. H. Westra, R. Daniel, K. V. Shah, and D. Sidransky Detection and Quantitation of Human Papillomavirus (HPV) DNA in the Sera of Patients with HPV-associated Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., November 1, 2000; 6(11): 4171 - 4175. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Feng, E. C. Ren, D. Liu, S. H. Chan, and H. Hu Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis J. Gen. Virol., October 1, 2000; 81(10): 2417 - 2423. [Abstract] [Full Text] |
||||
![]() |
Y.M. D. Lo Molecular Testing of Urine: Catching DNA on the Way Out Clin. Chem., August 1, 2000; 46(8): 1039 - 1040. [Full Text] [PDF] |
||||
![]() |
I. Botezatu, O.'g. Serdyuk, G. Potapova, V. Shelepov, R. Alechina, Y. Molyaka, V. Anan'ev, I. Bazin, A. Garin, M. Narimanov, et al. Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism Clin. Chem., August 1, 2000; 46(8): 1078 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Clementi Quantitative Molecular Analysis of Virus Expression and Replication J. Clin. Microbiol., June 1, 2000; 38(6): 2030 - 2036. [Full Text] |
||||
![]() |
Y. M. D. Lo, S.-F. Leung, L. Y. S. Chan, A. T. C. Chan, K.-W. Lo, P. J. Johnson, and D. P. Huang Kinetics of Plasma Epstein-Barr Virus DNA during Radiation Therapy for Nasopharyngeal Carcinoma Cancer Res., May 1, 2000; 60(9): 2351 - 2355. [Abstract] [Full Text] |
||||
![]() |
K. Shotelersuk, C. Khorprasert, S. Sakdikul, W. Pornthanakasem, N. Voravud, and A. Mutirangura Epstein-Barr Virus DNA in Serum/Plasma as a Tumor Marker for Nasopharyngeal Cancer Clin. Cancer Res., March 1, 2000; 6(3): 1046 - 1051. [Abstract] [Full Text] |
||||
![]() |
Y. M. Dennis Lo, L. Y. S. Chan, A. T. C. Chan, S.-F. Leung, K.-W. Lo, J. Zhang, J. C. K. Lee, N. M. Hjelm, P. J. Johnson, and D. P. Huang Quantitative and Temporal Correlation between Circulating Cell-Free Epstein-Barr Virus DNA and Tumor Recurrence in Nasopharyngeal Carcinoma Cancer Res., November 1, 1999; 59(21): 5452 - 5455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. D. Lo, I. H. N. Wong, J. Zhang, M. S. C. Tein, M. H. L. Ng, and N. M. Hjelm Quantitative Analysis of Aberrant p16 Methylation Using Real-Time Quantitative Methylation-specific Polymerase Chain Reaction Cancer Res., August 1, 1999; 59(16): 3899 - 3903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Lo, Y.M. D. Lo, S.-F. Leung, Y.-S. Tsang, L. Y.S. Chan, P. J. Johnson, N. M. Hjelm, J. C.K. Lee, and D. P. Huang Analysis of Cell-free Epstein-Barr Virus-associated RNA in the Plasma of Patients with Nasopharyngeal Carcinoma Clin. Chem., August 1, 1999; 45(8): 1292 - 1294. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |